当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 现金流量表

凯普生物

(300639)

  

流通市值:32.58亿  总市值:33.17亿
流通股本:6.35亿   总股本:6.47亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金189,409,150.321,078,014,877.59693,484,670.77445,799,579.1
  收到的税费返还9,330.828,881.42121,212.14121,127.62
  收到其他与经营活动有关的现金11,864,920.7841,254,332.0720,518,823.6416,745,086.38
  经营活动现金流入小计201,283,401.921,119,278,091.08714,124,706.55462,665,793.1
  购买商品、接受劳务支付的现金31,482,657.48161,336,433.12139,627,738.394,681,292.7
  支付给职工以及为职工支付的现金80,028,333.19322,961,488.93245,123,058.88170,111,506.17
  支付的各项税费15,192,312.9455,623,310.0337,743,624.1923,459,508.53
  支付其他与经营活动有关的现金49,629,272.86237,748,112.19170,419,884.97119,009,885.46
  经营活动现金流出小计176,332,576.47777,669,344.27592,914,306.34407,262,192.86
  经营活动产生的现金流量净额24,950,825.45341,608,746.81121,210,400.2155,403,600.24
二、投资活动产生的现金流量:
  收回投资收到的现金172,000,000745,342,727.59658,000,102.76405,000,102.76
  取得投资收益收到的现金427,510.522,245,585.831,887,967.821,309,106.63
  处置固定资产、无形资产和其他长期资产收回的现金净额717,0871,636,578.83605,350601,838
  收到的其他与投资活动有关的现金78,835,32840,000,000--
  投资活动现金流入小计251,979,925.52789,224,892.25660,493,420.58406,911,047.39
  购建固定资产、无形资产和其他长期资产支付的现金18,144,090.3692,394,164.8348,444,840.5732,087,894.92
  投资支付的现金202,694,787.92761,242,882.19631,500,000116,000,000
  取得子公司及其他营业单位支付的现金--5,700,000-
  支付其他与投资活动有关的现金350,990,716.7678,835,328--
  投资活动现金流出小计571,829,595.04932,472,375.02685,644,840.57148,087,894.92
  投资活动产生的现金流量净额-319,849,669.52-143,247,482.77-25,151,419.99258,823,152.47
三、筹资活动产生的现金流量:
  吸收投资收到的现金-8,000,0008,000,0008,000,000
  其中:子公司吸收少数股东投资收到的现金-8,000,0008,000,0008,000,000
  取得借款收到的现金-46,000,00046,000,00045,000,000
  收到其他与筹资活动有关的现金-5,812,675.91--
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-59,812,675.9154,000,00053,000,000
  偿还债务支付的现金-45,059,79223,035,1922,475,400
  分配股利、利润或偿付利息支付的现金435,472.514,884,299.563,032,190.391,576,370.55
  其中:子公司支付给少数股东的股利、利润-1,388,618.9--
  支付其他与筹资活动有关的现金11,835,806.37152,984,126.29104,708,934.93102,129,656.98
  筹资活动现金流出小计12,271,278.88202,928,217.85130,776,317.32106,181,427.53
  筹资活动产生的现金流量净额-12,271,278.88-143,115,541.94-76,776,317.32-53,181,427.53
四、汇率变动对现金及现金等价物的影响-11,941,768.92-9,394,780.053,388,635.5-3,176,317.34
五、现金及现金等价物净增加额-319,111,891.8745,850,942.0522,671,298.4257,869,007.84
  加:期初现金及现金等价物余额707,988,956.11662,115,776.09662,115,776.09662,115,776.09
  期末现金及现金等价物余额388,877,064.24707,966,718.14684,787,074.49919,984,783.93
补充资料:
  净利润--182,280,400.25--137,116,800.36
  资产减值准备-62,269,395.63-68,458,178.12
  固定资产和投资性房地产折旧-140,881,227.62-65,265,442.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-140,881,227.62-65,265,442.69
  无形资产摊销-12,850,546.28-6,738,050.65
  长期待摊费用摊销-17,824,727.67-14,995,090.89
  处置固定资产、无形资产和其他长期资产的损失--434,231.78--358,182.51
  固定资产报废损失-460,897.52-157,863.35
  公允价值变动损失--4,973,032.53--4,438,941.3
  财务费用-3,183,250.62--12,901,290.18
  投资损失-1,125,109.6-593,740.04
  递延所得税-351,826.49-7,062,072.76
  其中:递延所得税资产减少-19,550,575.54-12,384,607.7
    递延所得税负债增加--19,198,749.05--5,322,534.94
  存货的减少-8,368,583.97--4,523,876.37
  经营性应收项目的减少-337,928,885.4-81,525,773.55
  经营性应付项目的增加--60,501,918.98--29,294,125.51
  其他--1,139,339.49--3,852,064.3
  现金的期末余额-707,966,718.14-919,984,783.93
  减:现金的期初余额-662,115,776.09-662,115,776.09
  现金及现金等价物的净增加额-45,850,942.05-257,869,007.84
公告日期2026-04-292026-04-292025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑